News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Harlan M. Krumholz, MD

Articles by Harlan M. Krumholz, MD

Physician Characteristics and the Initiation of Beta-Adrenergic Blocking Agent Therapy After Acute Myocardial Infarction in a Managed Care Population

ByS. Nicole Fehrenbach, MPP,Daniel S. Budnitz, MD, MPH,Julie A. Gazmararian, MPH, PhD,Harlan M. Krumholz, MD

July 1st 2001

Variations in and Correlates of Length of Stay in Academic Hospitals among Patients with Heart Failure Resulting from Systolic Dysfunction

ByHarlan M. Krumholz, MD,Ya-ting Chen, PhD,W. David Bradford, PhD,Julie Cerese, RN, MSN

June 1st 1999

Trends in Costs of Percutaneous Transluminal Coronary Angioplasty

ByAsefeh Heiat, MD,Jennifer A. Mattera, MPH,Glen A. Henry, MD,Ya-ting Chen, PhD,Harlan M. Krumholz, MD

December 1st 1998

Differences in Physician Compensation for Cardiovascular Services by Age, Sex, and Race

ByHarlan M. Krumholz, MD,A. Mark Fendrick, MD,Christianna Williams, MA,William M. Hynes

April 1st 1997

Latest Updated Articles

Variations in and Correlates of Length of Stay in Academic Hospitals among Patients with Heart Failure Resulting from Systolic Dysfunction
Published: June 1st 1999 | Updated:
Physician Characteristics and the Initiation of Beta-Adrenergic Blocking Agent Therapy After Acute Myocardial Infarction in a Managed Care Population
Published: July 1st 2001 | Updated:
Trends in Costs of Percutaneous Transluminal Coronary Angioplasty
Published: December 1st 1998 | Updated:
Differences in Physician Compensation for Cardiovascular Services by Age, Sex, and Race
Published: April 1st 1997 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Understanding Real-World MRI Utilization for ED Dizziness: Ava L. Liberman, MD

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text